The World of Health & Medicine News

Former US President Biden diagnosed with ‘aggressive’ prostate cancer

Former US President Biden diagnosed with ‘aggressive’ prostate cancer

Former U.S. President Joe Biden has been diagnosed with an “aggressive form” of prostate cancer that has spread to his bones, his office said in a statement on Sunday.

Biden, 82, was diagnosed on Friday after experiencing urinary symptoms, and he and his family are reviewing treatment options with doctors, according to the statement.

“Cancer touches us all. Like so many of you, Jill and I have learned that we are strongest in the broken places. Thank you for lifting us up with love and support,” Biden said in an X post early on Monday.

Cancers that have spread, or metastasized, are considered Stage 4, the most advanced. Most prostate cancers are detected at an earlier stage.

According to the Centers for Disease Control and Prevention, of the 236,659 cases of prostate cancer diagnosed in 2021, 70% were diagnosed before the cancer had spread beyond the prostate. About 8% of new prostate cancer diagnoses that year involved advanced-stage disease.

“While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management,” Biden’s office said on Sunday.

Biden’s physical health and mental acuity drew scrutiny during his 2021-2025 presidency. He abruptly ended his bid for reelection last July, weeks after a halting performance during a debate against Republican Donald Trump prompted panic among his fellow Democrats.

President Trump, who has repeatedly berated Biden since taking office in January, expressed sympathy on Sunday for Biden and his wife, Jill, in a post on his social media platform Truth Social.

“Melania and I are saddened to hear about Joe Biden’s recent medical diagnosis,” he wrote, referring to first lady Melania Trump. “We extend our warmest and best wishes to Jill and the family, and we wish Joe a fast and successful recovery.”

Biden’s office said the cancer scored a nine out of 10 on the Gleason score grading system, which is used to help determine the aggressiveness of prostate cancer.

Dr. Herbert Lepor, an urologist at NYU Langone, said a score of nine is “very high risk,” but added that many men can live “five to 10 years and beyond” even with metastatic prostate cancer.

“Over the last decade, there have been many advances in the treatment of advanced prostate cancer,” he said.

Dr. Chris George, the medical director of the cancer program for the Northwestern Health Network, said prostate cancer is no longer curable once it spreads to the bones but that there are treatments that can control it.

spot_img

Explore more

spot_img

Health Rounds: Older diabetes drugs appear to slow prostate cancer in...

Health Rounds: Older diabetes drugs appear to slow prostate cancer in small study A class of older drugs used to treat type 2 diabetes may...

Sanofi to acquire Vigil Neuroscience in $470 million deal to boost...

Sanofi to acquire Vigil Neuroscience in $470 million deal to boost neurological pipeline Sanofi (SASY.PA), opens new tab will acquire Vigil Neuroscience (VIGL.O), opens new tab, a clinical-stage...

RFK Jr., grandkids swim in contaminated DC creek despite advice to...

RFK Jr., grandkids swim in contaminated DC creek despite advice to 'stay out' The nation's top health advisor spent time with his grandchildren on Mother's...

US CDC accepts recommendations for chikungunya vaccines

US CDC accepts recommendations for chikungunya vaccines  The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for chikungunya,...

Robert F. Kennedy Jr calls WHO ‘moribund’, urges others to quit

Robert F. Kennedy Jr calls WHO 'moribund', urges others to quit - U.S. Health and Human Services Secretary Robert F. Kennedy Jr. dismissed the World...

World Health Organization members vote in favour of global pandemic agreement

World Health Organization members vote in favour of global pandemic agreement Members of the World Health Organization voted emphatically in favour of a potentially groundbreaking...

Majority of Indian districts face high heatwave risk, study shows

Majority of Indian districts face high heatwave risk, study shows Nearly 60% of Indian districts, home to three-quarters of the population, face a "high to very high"...

Pfizer in deal with China’s 3SBio to license cancer drug candidate,...

Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake U.S. drugmaker Pfizer (PFE.N), opens new tab said it would license an experimental...